▶ 調査レポート

世界の急性虚血性脳卒中診断・治療市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Acute Ischemic Stroke Diagnosis and Treatment Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の急性虚血性脳卒中診断・治療市場規模・現状・予測(2021年-2027年) / Global Acute Ischemic Stroke Diagnosis and Treatment Market Size, Status and Forecast 2021-2027 / QYR2104Z0062資料のイメージです。• レポートコード:QYR2104Z0062
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥553,800 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥830,700 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,107,600 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、急性虚血性脳卒中診断・治療のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(コンピュータ断層撮影(CT)、磁気共鳴画像法(MRI)、頸部超音波、脳血管造影、心電図、心エコー検査、その他)、用途別市場規模(組織プラスミノーゲン活性化因子、抗凝固剤、抗血小板剤、降圧剤)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・急性虚血性脳卒中診断・治療の市場動向
・企業の競争状況、市場シェア
・急性虚血性脳卒中診断・治療の種類別市場規模(コンピュータ断層撮影(CT)、磁気共鳴画像法(MRI)、頸部超音波、脳血管造影、心電図、心エコー検査、その他)
・急性虚血性脳卒中診断・治療の用途別市場規模(組織プラスミノーゲン活性化因子、抗凝固剤、抗血小板剤、降圧剤)
・急性虚血性脳卒中診断・治療の北米市場規模2016-2027(アメリカ、カナダ)
・急性虚血性脳卒中診断・治療のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・急性虚血性脳卒中診断・治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・急性虚血性脳卒中診断・治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・急性虚血性脳卒中診断・治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott、Medtronic、Boston Scientific、Cordis、Philips、GE Healthcare、Siemens、Stryker、Genentech、Merck)
・結論

According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases.

Market Analysis and Insights: Global Acute Ischemic Stroke Diagnosis and Treatment Market
The global Acute Ischemic Stroke Diagnosis and Treatment market size is projected to reach US$ 1325.2 million by 2026, from US$ 1049.8 million in 2019, at a CAGR of 3.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Ischemic Stroke Diagnosis and Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Ischemic Stroke Diagnosis and Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Ischemic Stroke Diagnosis and Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Ischemic Stroke Diagnosis and Treatment market.

Global Acute Ischemic Stroke Diagnosis and Treatment Scope and Market Size
Acute Ischemic Stroke Diagnosis and Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Ischemic Stroke Diagnosis and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Computed Tomography (CT)
Magnetic resonance imaging (MRI)
Carotid Ultrasound
Cerebral Angiography
Electrocardiography
Echocardiography
Others

Segment by Application
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Medtronic
Boston Scientific
Cordis
Philips
GE Healthcare
Siemens
Stryker
Genentech

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Computed Tomography (CT)
1.2.3 Magnetic resonance imaging (MRI)
1.2.4 Carotid Ultrasound
1.2.5 Cerebral Angiography
1.2.6 Electrocardiography
1.2.7 Echocardiography
1.2.8 Others
1.3 Market by Application
1.3.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Tissue Plasminogen Activator
1.3.3 Anticoagulant
1.3.4 Antiplatelet
1.3.5 Antihypertensive
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Perspective (2016-2027)
2.2 Acute Ischemic Stroke Diagnosis and Treatment Growth Trends by Regions
2.2.1 Acute Ischemic Stroke Diagnosis and Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Ischemic Stroke Diagnosis and Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Acute Ischemic Stroke Diagnosis and Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Acute Ischemic Stroke Diagnosis and Treatment Industry Dynamic
2.3.1 Acute Ischemic Stroke Diagnosis and Treatment Market Trends
2.3.2 Acute Ischemic Stroke Diagnosis and Treatment Market Drivers
2.3.3 Acute Ischemic Stroke Diagnosis and Treatment Market Challenges
2.3.4 Acute Ischemic Stroke Diagnosis and Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Ischemic Stroke Diagnosis and Treatment Players by Revenue
3.1.1 Global Top Acute Ischemic Stroke Diagnosis and Treatment Players by Revenue (2016-2021)
3.1.2 Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Acute Ischemic Stroke Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Ischemic Stroke Diagnosis and Treatment Revenue
3.4 Global Acute Ischemic Stroke Diagnosis and Treatment Market Concentration Ratio
3.4.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Ischemic Stroke Diagnosis and Treatment Revenue in 2020
3.5 Acute Ischemic Stroke Diagnosis and Treatment Key Players Head office and Area Served
3.6 Key Players Acute Ischemic Stroke Diagnosis and Treatment Product Solution and Service
3.7 Date of Enter into Acute Ischemic Stroke Diagnosis and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Ischemic Stroke Diagnosis and Treatment Breakdown Data by Type
4.1 Global Acute Ischemic Stroke Diagnosis and Treatment Historic Market Size by Type (2016-2021)
4.2 Global Acute Ischemic Stroke Diagnosis and Treatment Forecasted Market Size by Type (2022-2027)

5 Acute Ischemic Stroke Diagnosis and Treatment Breakdown Data by Application
5.1 Global Acute Ischemic Stroke Diagnosis and Treatment Historic Market Size by Application (2016-2021)
5.2 Global Acute Ischemic Stroke Diagnosis and Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size (2016-2027)
6.2 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type
6.2.1 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021)
6.2.2 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2022-2027)
6.2.3 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2027)
6.3 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application
6.3.1 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2021)
6.3.2 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2022-2027)
6.3.3 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2027)
6.4 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country
6.4.1 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2016-2021)
6.4.2 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size (2016-2027)
7.2 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type
7.2.1 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021)
7.2.2 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2022-2027)
7.2.3 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2027)
7.3 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application
7.3.1 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2021)
7.3.2 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2022-2027)
7.3.3 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2027)
7.4 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country
7.4.1 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2016-2021)
7.4.2 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size (2016-2027)
8.2 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type
8.2.1 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application
8.3.1 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Region
8.4.1 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size (2016-2027)
9.2 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type
9.2.1 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2027)
9.3 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application
9.3.1 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2027)
9.4 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country
9.4.1 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size (2016-2027)
10.2 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type
10.2.1 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application
10.3.1 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country
10.4.1 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.1.4 Abbott Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.2.4 Medtronic Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.2.5 Medtronic Recent Development
11.3 Boston Scientific
11.3.1 Boston Scientific Company Details
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.3.4 Boston Scientific Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.3.5 Boston Scientific Recent Development
11.4 Cordis
11.4.1 Cordis Company Details
11.4.2 Cordis Business Overview
11.4.3 Cordis Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.4.4 Cordis Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.4.5 Cordis Recent Development
11.5 Philips
11.5.1 Philips Company Details
11.5.2 Philips Business Overview
11.5.3 Philips Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.5.4 Philips Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.5.5 Philips Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.6.4 GE Healthcare Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.6.5 GE Healthcare Recent Development
11.7 Siemens
11.7.1 Siemens Company Details
11.7.2 Siemens Business Overview
11.7.3 Siemens Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.7.4 Siemens Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.7.5 Siemens Recent Development
11.8 Stryker
11.8.1 Stryker Company Details
11.8.2 Stryker Business Overview
11.8.3 Stryker Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.8.4 Stryker Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.8.5 Stryker Recent Development
11.9 Genentech
11.9.1 Genentech Company Details
11.9.2 Genentech Business Overview
11.9.3 Genentech Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.9.4 Genentech Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.9.5 Genentech Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.10.4 Merck Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.10.5 Merck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Ischemic Stroke Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Computed Tomography (CT)
Table 3. Key Players of Magnetic resonance imaging (MRI)
Table 4. Key Players of Carotid Ultrasound
Table 5. Key Players of Cerebral Angiography
Table 6. Key Players of Electrocardiography
Table 7. Key Players of Echocardiography
Table 8. Key Players of Others
Table 9. Global Acute Ischemic Stroke Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Acute Ischemic Stroke Diagnosis and Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Acute Ischemic Stroke Diagnosis and Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share by Regions (2016-2021)
Table 13. Global Acute Ischemic Stroke Diagnosis and Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share by Regions (2022-2027)
Table 15. Acute Ischemic Stroke Diagnosis and Treatment Market Trends
Table 16. Acute Ischemic Stroke Diagnosis and Treatment Market Drivers
Table 17. Acute Ischemic Stroke Diagnosis and Treatment Market Challenges
Table 18. Acute Ischemic Stroke Diagnosis and Treatment Market Restraints
Table 19. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share by Players (2016-2021)
Table 21. Global Top Acute Ischemic Stroke Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Ischemic Stroke Diagnosis and Treatment as of 2020)
Table 22. Ranking of Global Top Acute Ischemic Stroke Diagnosis and Treatment Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Acute Ischemic Stroke Diagnosis and Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Acute Ischemic Stroke Diagnosis and Treatment Product Solution and Service
Table 26. Date of Enter into Acute Ischemic Stroke Diagnosis and Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Type (2016-2021)
Table 30. Global Acute Ischemic Stroke Diagnosis and Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Acute Ischemic Stroke Diagnosis and Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Application (2016-2021)
Table 34. Global Acute Ischemic Stroke Diagnosis and Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott Acute Ischemic Stroke Diagnosis and Treatment Product
Table 69. Abbott Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Medtronic Company Details
Table 72. Medtronic Business Overview
Table 73. Medtronic Acute Ischemic Stroke Diagnosis and Treatment Product
Table 74. Medtronic Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 75. Medtronic Recent Development
Table 76. Boston Scientific Company Details
Table 77. Boston Scientific Business Overview
Table 78. Boston Scientific Acute Ischemic Stroke Diagnosis and Treatment Product
Table 79. Boston Scientific Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 80. Boston Scientific Recent Development
Table 81. Cordis Company Details
Table 82. Cordis Business Overview
Table 83. Cordis Acute Ischemic Stroke Diagnosis and Treatment Product
Table 84. Cordis Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 85. Cordis Recent Development
Table 86. Philips Company Details
Table 87. Philips Business Overview
Table 88. Philips Acute Ischemic Stroke Diagnosis and Treatment Product
Table 89. Philips Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 90. Philips Recent Development
Table 91. GE Healthcare Company Details
Table 92. GE Healthcare Business Overview
Table 93. GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Product
Table 94. GE Healthcare Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 95. GE Healthcare Recent Development
Table 96. Siemens Company Details
Table 97. Siemens Business Overview
Table 98. Siemens Acute Ischemic Stroke Diagnosis and Treatment Product
Table 99. Siemens Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 100. Siemens Recent Development
Table 101. Stryker Company Details
Table 102. Stryker Business Overview
Table 103. Stryker Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 104. Stryker Recent Development
Table 105. Genentech Company Details
Table 106. Genentech Business Overview
Table 107. Genentech Acute Ischemic Stroke Diagnosis and Treatment Product
Table 108. Genentech Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 109. Genentech Recent Development
Table 110. Merck Company Details
Table 111. Merck Business Overview
Table 112. Merck Acute Ischemic Stroke Diagnosis and Treatment Product
Table 113. Merck Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021) & (US$ Million)
Table 114. Merck Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share by Type: 2020 VS 2027
Figure 2. Computed Tomography (CT) Features
Figure 3. Magnetic resonance imaging (MRI) Features
Figure 4. Carotid Ultrasound Features
Figure 5. Cerebral Angiography Features
Figure 6. Electrocardiography Features
Figure 7. Echocardiography Features
Figure 8. Others Features
Figure 9. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share by Application: 2020 VS 2027
Figure 10. Tissue Plasminogen Activator Case Studies
Figure 11. Anticoagulant Case Studies
Figure 12. Antiplatelet Case Studies
Figure 13. Antihypertensive Case Studies
Figure 14. Acute Ischemic Stroke Diagnosis and Treatment Report Years Considered
Figure 15. Global Acute Ischemic Stroke Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Acute Ischemic Stroke Diagnosis and Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share by Regions: 2020 VS 2027
Figure 18. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share by Regions (2022-2027)
Figure 19. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share by Players in 2020
Figure 20. Global Top Acute Ischemic Stroke Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Ischemic Stroke Diagnosis and Treatment as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Acute Ischemic Stroke Diagnosis and Treatment Revenue in 2020
Figure 22. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Type (2016-2021)
Figure 23. Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Type (2022-2027)
Figure 24. North America Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Acute Ischemic Stroke Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 26. North America Acute Ischemic Stroke Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 27. North America Acute Ischemic Stroke Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 28. United States Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Acute Ischemic Stroke Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 32. Europe Acute Ischemic Stroke Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 33. Europe Acute Ischemic Stroke Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 34. Germany Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Share by Region (2016-2027)
Figure 44. China Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 52. Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 53. Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 54. Mexico Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Share by Country (2016-2027)
Figure 60. Turkey Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Acute Ischemic Stroke Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Abbott Revenue Growth Rate in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
Figure 64. Medtronic Revenue Growth Rate in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
Figure 65. Boston Scientific Revenue Growth Rate in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
Figure 66. Cordis Revenue Growth Rate in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
Figure 67. Philips Revenue Growth Rate in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
Figure 68. GE Healthcare Revenue Growth Rate in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
Figure 69. Siemens Revenue Growth Rate in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
Figure 70. Stryker Revenue Growth Rate in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
Figure 71. Genentech Revenue Growth Rate in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
Figure 72. Merck Revenue Growth Rate in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed